Clinical Study

Nemolizumab In Subjects With Prurigo Nodularis

Posted Date: Jan 3, 2022

  • Investigator: Alan Fleischer
  • Specialties:
  • Type of Study: Drug

This is a continuation of a randomized control trial of nemolizumab, an inti-itch drug


Prior Participation In Clinical Trial


Itch, Open Label Extension

For More Information:

Lyssa Casale
513- 558-5650

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.